UCB Share Price CINNOBER BOAT
Stocks
0NZT
BE0003739530
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 262.25 EUR | 0.00% |
|
0.00% | - |
| 25/06 | US prices for new drugs fell in 2025 as fewer costly gene therapies were launched | RE |
| 22/06 | UBS Trims UCB's PT, Affirms Buy Rating | MT |
| Market Cap | 5.02TCr 5.73TCr 4.63TCr 4.32TCr 8.14TCr 5,41800Cr 8.28TCr 56TCr 22TCr 2,67400Cr 22TCr 21TCr 9,31500Cr | P/E 2026 * |
28.3x | P/E 2027 * | 22.1x |
|---|---|---|---|---|---|
| Enterprise Value | 4.92TCr 5.62TCr 4.54TCr 4.24TCr 7.99TCr 5,31800Cr 8.13TCr 55TCr 21TCr 2,62400Cr 21TCr 21TCr 9,14300Cr | EV / Sales 2026 * |
5.77x | EV / Sales 2027 * | 4.91x |
| Free-Float |
61.59% | Yield 2026 * |
0.56% | Yield 2027 * | 0.57% |
Last Transcript: UCB
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 01/01/2015 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 59 | 01/07/2020 |
Alistair Henry
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 01/01/2012 | |
| Director/Board Member | 67 | 01/01/2015 | |
| Director/Board Member | 56 | 24/04/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 5.73TCr | |
| -0.68% | +1.63% | +19.64% | -12.59% | 6.43TCr | |
| -3.94% | +39.10% | +39.10% | +39.10% | 4.34TCr | |
| -0.56% | +1.65% | -51.04% | -58.77% | 3.8TCr | |
| -0.56% | +9.54% | +72.00% | -24.17% | 3.2TCr | |
| +3.52% | +17.95% | +160.78% | -40.78% | 2.77TCr | |
| +0.05% | +9.78% | +68.30% | +84.11% | 2.29TCr | |
| -0.56% | +5.64% | +2.91% | +174.96% | 1.77TCr | |
| -0.13% | -0.94% | +60.31% | +119.58% | 1.64TCr | |
| +2.49% | +7.59% | +71.01% | +329.30% | 1.41TCr | |
| Average | -0.03% | +6.92% | +49.22% | +67.86% | 3.07TCr | |
| Weighted average by Cap. | -0.40% | +6.00% | +41.14% | +30.36% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 853.38Cr 974.95Cr 787.76Cr 734.82Cr 1.38TCr 92TCr 1.41TCr 9.45TCr 3.67TCr 45TCr 3.66TCr 3.58TCr 1,58500Cr | 962.63Cr 1.1TCr 888.61Cr 828.9Cr 1.56TCr 1,04000Cr 1.59TCr 11TCr 4.14TCr 51TCr 4.13TCr 4.04TCr 1,78800Cr |
| Net income | 174.65Cr 199.53Cr 161.22Cr 150.39Cr 283.35Cr 19TCr 288.42Cr 1.93TCr 750.78Cr 9.31TCr 749.64Cr 732.9Cr 32TCr | 228.64Cr 261.22Cr 211.06Cr 196.88Cr 370.95Cr 25TCr 377.59Cr 2.53TCr 982.88Cr 12TCr 981.39Cr 959.48Cr 42TCr |
| Net Debt | -93Cr -105.68Cr -85Cr -80Cr -150.08Cr -9.99TCr -152.77Cr -1.02TCr -397.66Cr -4.93TCr -397.05Cr -388.19Cr -17TCr | -293.23Cr -335Cr -270.68Cr -252.49Cr -475.73Cr -32TCr -484.24Cr -3.25TCr -1.26TCr -16TCr -1.26TCr -1.23TCr -54TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- UCB Stock
- 0NZT Stock
Select your edition
All financial news and data tailored to specific country editions
